Results 71 to 80 of about 51,886 (205)

Bullous pyoderma gangrenosum and myelodysplastic syndrome [PDF]

, 2006
Pyoderma gangrenosum can present as a cutaneous manifestation of paraneoplastic syndromes. A case of bullous pyoderma gangrenosum associated with bicytopenia is described.
Almeida, Fernando Augusto De, Batista, Mariana Dias, Chauffaille, Maria de Lourdes Lopes Ferrari, Fernandes, Ricardo Limongi, Ikino, Juliana Kida, Michalany, Nílceo Schwery, Pinheiro, Ronald Feitosa, Rocha, Marco Alexandre Dias Da   +7 more
core   +4 more sources

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

Haematologica, 2016
Disease relapse is the most common cause of treatment failure after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndromes, yet treatment options for such patients remain extremely limited.
Charles Craddock, Myriam Labopin, Marie Robin, Juergen Finke, Patrice Chevallier, Ibrahim Yakoub-Agha, Jean Henri Bourhis, Henrik Sengelov, Didier Blaise, Thomas Luft, Michael Hallek, Nicolaus Kröger, Arnon Nagler, Mohamad Mohty   +13 more
doaj   +1 more source

CLINICAL APPLICABILITY OF PROPOSED ALGORITHM FOR IDENTIFYING INDIVIDUALS AT RISK FOR HEREDITARY HEMATOLOGIC MALIGNANCIES [PDF]

, 2017
Over the past decade, more than 12 genes have been identified to cause hereditary predispositions to hematologic malignancies. These syndromes are characterized by an increased risk to develop myelodysplastic syndrome (MDS), acute myeloid leukemia (AML),
Clifford, Maggie
core   +1 more source

Será que a soja aumenta as contagens sanguíneas em síndrome mielodisplásica? [PDF]

, 2010
Myelodysplastic syndromes (MDS) are a group of clonal stem cell diseases characterized by ineffective hematopoiesis, bone marrow hyperproliferation, cytopenias in peripheral blood and risk of transformation into acute leukemia.
Atallah, Álvaro Nagib, Carvalho, V. M., Chauffaille, Maria de Lourdes Lopes Ferrari, Claricia, E., Panizzi, M. C. C., Pinheiro, R. F., Sandes, Alex Freire, Sesso, Ricardo de Castro Cintra, Viana, T. A. O. F., Yamamoto, Mihoko   +9 more
core   +2 more sources

Familial myelodysplastic syndromes: a review of the literature

Haematologica, 2011
Familial cases of myelodysplastic syndromes are rare, but are immensely valuable for the investigation of the molecular pathogenesis of myelodysplasia in general.
Elena Liew, Carolyn Owen
doaj   +1 more source

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with less than or equal to 30% blasts [PDF]

, 2017
Treatment with azacitidine (AZA), a demethylating agent, prolonged overall survival (OS) vs conventional care in patients with higher-risk myelodysplastic syndromes (MDS). As median survival with monotherapy is
AM Zeidan, AO Soriano, BD Cheson, BD Cheson, CJ Clopper, D Merkel, DJ DeAngelo, E Raffoux, G Garcia-Manero, G Garcia-Manero, G Garcia-Manero, H Dombret, H Khan, J Babb, JP Issa, JP Issa, JP Laubach, L Maurillo, L Pleyer, M Kirschbaum, M Lubbert, Mikkael A. Sekeres, P Atadja, P Fenaux, P Fenaux, P Maslak, P Tan, PG Richardson, SD Gore, SD Nimer, T Prebet, TE Fandy, W Blum, W Fiskus, Y Ofran, YG Lee   +35 more
core   +2 more sources

Patient Attitudes Toward Genetic Testing for Inherited Predispositions to Hematologic Malignancies [PDF]

, 2018
Although inherited predispositions to hematologic malignancies have previously been considered extremely rare, approximately 12 causative genes have been implicated in the last decade.
Beecroft, Taylor
core   +1 more source

Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes [PDF]

, 2013
Background: Myelodysplastic syndromes (MDS) are a group of heterogeneous diseases with variable clinical course. Predicting disease progression is difficult due to lack of specific molecular marker(s).
Chai, Li, Chen, Qian, Cui, Wei, Guo, Ye, Ning, Ning, Tong, Chunrong, Wang, Fei, Xu, Xiaodong, Xu, Yonggang, Yang, Zhuo, Zhang, Yujuan   +10 more
core   +3 more sources

Myelodysplastic syndromes: Classification

Journal of Applied Hematology, 2014
The updated WHO classification system for myelodysplastic syndromes (MDS) includes some new entities, in particular "refractory cytopenias with unilineage dysplasia (RCUD)". The following review article presents a short overview regarding all subvariants
Hans Peter Horny
doaj   +1 more source

The incidence of myelodysplastic syndromes in Western Greece is increasing. [PDF]

, 2013
Descriptive epidemiology of the myelodysplastic syndromes (MDS) is always interesting and may reveal time-dependent and geographical variations, as well as occupational exposure. Epidemiological data in Greece are not available by now.
Aktypi, A, Alamanos, Y, Avgerinou, C, Kaiafas, P, Karakantza, M, Kouraklis, A, Labropoulou, V, Lampropoulou, P, Melachrinou, M, Raptis, C, Symeonidis, A, Tavernarakis, I, Zikos, P   +12 more
core   +1 more source